I’m not so concerned about timelines either. There are plenty of milestones coming up prior to FDA approval that should help increase value.
As a comparison look at EBR ($359m MC) & AVR ($331m MC) both have a significantly higher MC than EMV ($181m MC) yet they are still awaiting FDA approval. (Albeit both Class 3 devices).
I’m not so concerned about timelines either. There are plenty of...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.12 |
Change
-0.030(1.40%) |
Mkt cap ! $181.1M | |||
| Open | High | Low | Value | Volume |
| $2.15 | $2.18 | $2.10 | $93.15K | 43.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 194 | $2.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.15 | 11452 | 1 |
View Market Depth
| Last trade - 15.51pm 16/08/2024 (20 minute delay) ? |
| EMV (ASX) Chart |